LYPLAL1 and neoplasm: Here, we identified a novel tumor-suppressed lncRNA LYPLAL1-DT (lysophospholipase like 1 divergent transcript) in TNBC, which indicated a favorable prognosis and curbed the proliferative and metastatic abilities of TNBC cells whether in vitro or in vivo.